SCHEMBL31437179

CC(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C

nearest known ligand 0.56

Predicted protein targets (top 9)

	gene	UniProt	supporting neighbours	confidence
▸	TFPI	P10646	5/20	0.56

▸	NPY2R	P49146	7/20	0.54

▸	NPY4R	P50391	7/20	0.54

▸	NPY5R	Q15761	7/20	0.54

▸	NPY1R	P25929	5/20	0.54

▸	OPRM1	P35372	5/20	0.52

▸	OPRK1	P41145	5/20	0.52

▸	RAMP3	O60896	2/20	0.51

▸	CALCR	P30988	2/20	0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31437214	0.97	NPY2R (0.56)	TFPINPY2RNPY4RNPY5RNPY1R
SCHEMBL31467768	0.95	CXCR4 (0.55)	TFPINPY2RNPY4RNPY5RNPY1R
SCHEMBL30562225	0.93	NPY2R (0.56)	TFPINPY2RNPY4RNPY5RNPY1R
SCHEMBL31467766	0.92	NPY2R (0.54)	TFPINPY2RNPY4RNPY5RNPY1R
SCHEMBL31467754	0.88	KDM1A (0.59)	TFPINPY2RNPY4RNPY5RNPY1R
SCHEMBL31437159	0.87	CXCR4 (0.54)	TFPINPY2RNPY4RNPY5RNPY1R
Bpc-157 SCHEMBL29406057	0.87	NPY2R (0.48)	TFPINPY2RNPY4RNPY5RNPY1R
Bpc-157 SCHEMBL30880330	0.87	NPY2R (0.48)	TFPINPY2RNPY4RNPY5RNPY1R
SCHEMBL31386380	0.85	CXCR4 (0.56)	TFPIOPRM1OPRK1RAMP3CALCR
SCHEMBL30280344	0.84	NPY2R (0.60)	TFPINPY2RNPY4RNPY5RNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
WO-2025037993-A1	DOSAGE FORM FOR PEPTIDE AGENTS	MAJEWSKI FILIP (PL)	2025-02-20	—	—	WO	disclosed
WO-2025037992-A1	NEW PEPTIDES AND USE THEREOF	MAJEWSKI FILIP (PL)	2025-02-20	—	—	WO	disclosed